Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescription of Hemangiol in the Treatment of Proliferative Infantile Hemangiomas Requiring Systemic Treatment: Post Marketing Surveillance Study

NCT04105517 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04105517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04105517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescription of Hemangiol in the Treatment of Proliferative Infantile Hemangiomas Requiring Systemic Treatment: Post Marketing Surveillance Study
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
July 1, 2019
Completion date
October 30, 2019
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma